Du et al. (2009) demonstrated vitamin D3 pre-treatment of monocytes from T2D patients and controls resulted in similar TLR2 and TLR4 expression, NF-κB p65 phosphorylation state, and IL-1β and TNF-α expression in the two groups. This evidence concerns the gene IL1B and type 2 diabetes mellitus.